Logo small

ABM will test utility of endometriosis test

MedExpress Team

Published March 12, 2024 08:59

ABM will test utility of endometriosis test - Header image
Endometriosis is a condition that affects about 6 to 10% of women between the ages of 15 and 49. As experts estimate, the disease may affect up to 3 million women in our country. The main problem is the late diagnosis of the disease, after an average of 6-8 years of pain disabling women from normal functioning in society and from professional activity. The Medical Research Agency project is intended to address the challenge of the need for rapid diagnosis of endometriosis.

Endometriosis is characterized by the presence of endometrial cells (endometrium) outside the uterine cavity. These cells are still secretory active and, responding to hormonal changes during the menstrual cycle, cause a chronic inflammatory response in the body. In addition, endometriosis can alsȯ cause reduced fertility. More accessible diagnostics may be a lifesaver in the fight against the disease. Accordingly, the Medical Research Agency is working hard to launch a project to test the clinical utility of the EndoRNA test in a population of women with suspected endometriosis.

Until now, the only certain method of confirming endometriosis was surgery - laparoscopy. The EndoRNA test, on the other hand, is an alternative for those women who want to be sure if they have e...

Content locked

To gain access to the complete English section of the, kindly reach out to us at [email protected].

If you already have an account, please log in


endometrioza / ABM

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also